Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years

INTRODUCTION: Data from clinical studies on the long-term efficacy and safety of anti-tumor necrosis factor (TNF)-α therapy in patients with ankylosing spondylitis (AS) are scarce. This is the first report on continuous treatment with the TNFα fusion protein etanercept over seven years (y). METHODS:...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Baraliakos, Xenofon, Haibel, Hildrun, Fritz, Claudia, Listing, Joachim, Heldmann, Frank, Braun, Juergen, Sieper, Joachim
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2013
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4060369/
https://ncbi.nlm.nih.gov/pubmed/23786760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar4244
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller